ClinicalTrials.gov. NCT04573478. A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients with IgA Nephropathy at Risk of Progressive Loss of Renal Function. Available ...
NEW YORK, NY / ACCESS Newswire / January 20, 2026 / At first glance, the announcement that SMX (NASDAQ:SMX) has opened ...
WASHINGTON, Jan 27 (Reuters) - Grain trader Archer-Daniels-Midland Company (ADM.N), opens new tab has agreed to pay a $40 million civil penalty to settle charges from the U.S. Securities and Exchange ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results